发明名称 PANCREATIC INSULIN-PRODUCING BETA-CELL LINES DERIVED FROM HUMAN PLURIPOTENT STEM CELLS
摘要 Production of beta-cells from stem cells from pluripotent stem cells have always been significantly lacking in at least one of the following properties: 1) functional properties related to insulin-production and glucose signaling response, 2) mature phenotype such as biochemical markers or cell structures, 3) efficiency in production of differentiated cells. Described herein is multistep differentiation protocol which substantially overcomes all of the existing limitations. Pluripotent stem cells, including induced pluripotent stem cells (iPSCs), and embryonic stem cells (ESCs) can be differentiated using an embryoid body (EB) formation step, followed by B maturation via endothelial cells (EC) co-culturing and incubation with a sequential series of bone morphogenic protein (BMP)-related growth factor cocktails. The resulting cells displayed functional properties, including insulin-production and glucose signaling response, and mature phenotype of C-peptide expression.
申请公布号 WO2014130887(A1) 申请公布日期 2014.08.28
申请号 WO2014US17823 申请日期 2014.02.21
申请人 CEDARS-SINAI MEDICAL CENTER 发明人 TALAVERA-ADAME, DODANIM;DAFOE, DONALD C.
分类号 C12N5/00;C12N5/02 主分类号 C12N5/00
代理机构 代理人
主权项
地址